CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.

When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that challenged the traditional research model.

For this week’s Open Questions column, Dhruv Khullar is filling in for Joshua Rothman. When David Fajgenbaum was a twenty-five-year-old medical student, at the University of Pennsylvania, he started ...

Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to produce the treatment for more patients. Gene therapies for rare diseases are ...

The MarketWatch News Department was not involved in the creation of this content. Harnessing the vitality of a clone while neutralizing ethical controversies through a breakthrough 'Therapeutic ...

The clock inside Kim Stephens’ head runs toward a time when her son, Cole, may no longer be here. “I know [the clock is ...

A tick protein that inhibits multiple immune signals could lead to better treatments for autoimmune diseases and inflammation ...

Penn State Health will now offer a new treatment for movement disorders such as Parkinson’s disease and essential tremor.

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to appear soon after birth. To date, there haven’t been many reliable ...

CNBC Cures aims to help raise awareness of rare diseases and improve patient outcomes for people living with them. Led by "Squawk Box" anchor Becky Quick, the initiative was inspired by her family's ...

We preselected all newsletters you had before unsubscribing.

Harnessing the vitality of a clone while neutralizing ethical controversies through a breakthrough 'Therapeutic Cloning' protocol—ushering in a new era of regenerative medicine to conquer cancer, ...